Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class ASSE: 688336

Announcement on Voluntary Disclosure of New Drug Application Acceptance for the Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection

· Issued by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of New Drug Application Acceptance for the Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis